Albayrak A, Başgut B, Bıkmaz GA, Karahalil B. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital. BMC Health Serv Res. 2022;22(1):79.

Yee GC, Haas CE. Standards of practice for clinical pharmacists: the time has come. Pharmacotherapy. 2014;34(8):769-70.

Gayathri B, Gayathri B, Divasish L, Soni M, Hup G, Prasath K. Drug related problems: a systemic literature review. Int J Pharm Ther. 2018;9(1):1409-15.

Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-43.

Pharmaceutical Care Network Europe Foundation. Classification for Drug related problems 2017 [Available from: https://www.pcne.org/upload/files/230_PCNE_classification_V8-02.pdf].

Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Dicp. 1990;24(11):1093-7.

Aljadhey H, Mahmoud MA, Ahmed Y, Sultana R, Zouein S, Alshanawani S, et al. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study. BMJ Open. 2016;6(7):e010831.

Alblooshi BH, Baig MR, Roos JF. Clinical Pharmacist Interventions in identification and prevention of drug related problems in a tertiary care hospital in United Arab Emirates. J Hosp Pharmacy. 2021;16(2):10.

Al Zahawi RH, Baig MR, Thomas D, Al Meslamani AZ. Benchmarking clinical pharmacy services in the United Arab Emirates with United States of America and Sweden. J Pharm Pharmacogn Res. 2021;9(6):780-9.

Azhar S, Hassali MA, Ibrahim MI, Ahmad M, Masood I, Shafie AA. The role of pharmacists in developing countries: the current scenario in Pakistan. Hum Resour Health. 2009;7:54.

Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian J Psychol Med. 2013;35(2):121-6.

CSIR. Project report. 2023;10:110-7.

Berger V, Sommer C, Boje P, Hollmann J, Hummelt J, König C, et al. The impact of pharmacists' interventions within the Closed Loop Medication Management process on medication safety: An analysis in a German university hospital. Front Pharmacol. 2022;13:1030406.

Levy ER, Swami S, Dubois SG, Wendt R, Banerjee R. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010. Infect Control Hosp Epidemiol. 2012;33(4):346-53.

Rutledge-Taylor K, Matlow A, Gravel D, Embree J, Le Saux N, Johnston L, et al. A point prevalence survey of health care-associated infections in Canadian pediatric inpatients. Am J Infect Control. 2012;40(6):491-6.

Dubai Statistics Center. Population Bulletin Emirate of Dubai 2022 [Available from: https://www.dsc.gov.ae/Publication/Population%20Bulletin%20Emirate%20of%20Dubai-2022.pdf.

Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, et al. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci Rep. 2021;11(1):883.

Babelghaith SD, Wajid S, Alrabiah Z, Othiq MAM, Alghadeer S, Alhossan A, et al. Drug-Related Problems and Pharmacist Intervention at a General Hospital in the Jazan Region, Saudi Arabia. Risk Manag Healthc Policy. 2020;13:373-8.

Tefera GM, Zeleke AZ, Jima YM, Kebede TM. Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study. Drug Healthc Patient Saf. 2020;12:71-83.

Ali MAS, Khedr EMH, Ahmed FAH, Mohamed NNE. Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases. Int J Clin Pharm. 2018;40(5):1257-64.

Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol. 2017;18(1):52.

Sutherland A, Phipps DL, Tomlin S, Ashcroft DM. Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review. BMC Pediatr. 2019;19(1):486.

Nasir BB, Berha AB, Gebrewold MA, Yifru YM, Engidawork E, Woldu MA. Drug therapy problems and treatment satisfaction among ambulatory patients with epilepsy in a specialized hospital in Ethiopia. PLoS One. 2020;15(1):e0227359.

Newman TV, San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Adm Pharm. 2020;16(9):1155-65.

Audurier Y, Chapet N, Renaudin P, Bons C, Mathieu B, Theret S, et al. Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients? Int J Clin Pract. 2020;74(9):e13531.

Thapa P, Lee SWH, Kc B, Dujaili JA, Mohamed Ibrahim MI, Gyawali S. Pharmacist-led intervention on chronic pain management: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(8):3028-42.

Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 2016;71(4):1106-17.

Somers A, Spinewine A, Spriet I, Steurbaut S, Tulkens P, Hecq JD, et al. Development of clinical pharmacy in Belgian hospitals through pilot projects funded by the government. Acta Clin Belg. 2019;74(2):75-81.

Alahmadi YM, Alharbi MA, Almusallam AJ, Alahmadi RY, Alolayan SO. Incidence of Medication Errors in King Fahad Hospital Madina Saudi Arabia. Braz J Pharm Sci. 2022;58:e201196.

Burton ME, Munger MA, Bednarczyk EM, Davis LE, Davis GA, Elliott ME, et al. Update: the clinical pharmacist as principal investigator. Pharmacotherapy. 2010;30(12):1314.

Kharaba Z, Moutraji SA, Khawaldeh RAA, Alfoteih Y, Meslamani AZA. What has changed in the pharmaceutical care after COVID-19: Pharmacists' perspective. Pharm Pract (Granada). 2022;20(2):2656.

Principi N, Esposito S. Antimicrobial stewardship in paediatrics. BMC Infect Dis. 2016;16(1):424.

Tong EY, Edwards G, Hua PU, Yip G. Systematic review of clinical outcomes of clinical pharmacist roles in hospitalised general medicine patients. J Pharm Pract Res. 2020;50(4):297-307.

Abunahlah N, Elawaisi A, Velibeyoglu FM, Sancar M. Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey. Int J Clin Pharm. 2018;40(2):360-7.

Demoz GT, Berha AB, Alebachew Woldu M, Yifter H, Shibeshi W, Engidawork E. Drug therapy problems, medication adherence and treatment satisfaction among diabetic patients on follow-up care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. PLoS One. 2019;14(10):e0222985.

Hadi MA, Alldred DP. Promoting the role of pharmacists in chronic pain management: how can we make an impact on policy and practice? Int J Pharm Pract. 2015;23(3):165-6.

Ahmed E. 4.12The contribution of the clinical pharmacist in palliative care. In: Cherny NI, Fallon MT, Kaasa S, Portenoy RK, Currow DC, Cherny NI, et al., editors. Oxford Textbook of Palliative Medicine: Oxford University Press; 2021. p. 248–54.

Burstin H, Johnson K. Getting to better care and outcomes for diabetes through measurement. Am J Manag Care. 2016;22(4 Spec No.):Sp145-sp6.

Ragab MH, Al-Hindi MY, Alrayees MM. Neonatal parenteral nutrition: Review of the pharmacist role as a prescriber. Saudi Pharm J. 2016;24(4):429-40.

Sin CM, Huynh C, Dahmash D, Maidment ID. Factors influencing the implementation of clinical pharmacy services on paediatric patient care in hospital settings. Eur J Hosp Pharm. 2022;29(4):180-6.

Flannery DD, Swami S, Chan S, Eppes S. Prescriber perceptions of a pediatric antimicrobial stewardship program. Clin Pediatr (Phila). 2014;53(8):747-50.

Althomali A, Altowairqi A, Alghamdi A, Alotaibi M, Althubaiti A, Alqurashi A, et al. Impact of Clinical Pharmacist Intervention on Clinical Outcomes in the Critical Care Unit, Taif City, Saudi Arabia: A Retrospective Study. Pharmacy (Basel). 2022;10(5):108.

Arredondo E, Udeani G, Horseman M, Hintze TD, Surani S. Role of Clinical Pharmacists in Intensive Care Units. Cureus. 2021;13(9):e17929.

Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Critical care pharmacy services in United States hospitals. Ann Pharmacother. 2006;40(4):612-8.

Almansour HA, Aloudah NM, Alhawassi TM, Chaar B, Krass I, Saini B. Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis. Saudi Pharm J. 2020;28(5):529-37.

Eldin MK, Mohyeldin M, Zaytoun GA, Elmaaty MA, Hamza M, Fikry S, et al. Factors hindering the implementation of clinical pharmacy practice in Egyptian hospitals. Pharm Pract (Granada). 2022;20(1):2607.

Casper EA, El Wakeel LM, Saleh MA, El-Hamamsy MH. Management of pharmacotherapy-related problems in acute coronary syndrome: Role of clinical pharmacist in cardiac rehabilitation unit. Basic Clin Pharmacol Toxicol. 2019;125(1):44-53.

Anderson SL, Marrs JC. A Review of the Role of the Pharmacist in Heart Failure Transition of Care. Adv Ther. 2018;35(3):311-23.

Seid E, Engidawork E, Alebachew M, Mekonnen D, Berha AB. Evaluation of drug therapy problems, medication adherence and treatment satisfaction among heart failure patients on follow-up at a tertiary care hospital in Ethiopia. PLoS One. 2020;15(8):e0237781.

Forinash AB, Chamness D, Yancey A, Mathews K, Miller C, Thompson J, et al. Physician satisfaction with clinical pharmacist services in an obstetrics and gynecology teaching clinic. J Pharm Technol. 2016;32(5):191-5.

Adusumilli P, Adepu R. Drug related problems: an over view of various classification systems. Asian J Pharm Clin Res. 2014;7(4):7-10.